Work

Faculty Opinions recommendation of SAR405838: A novel and potent inhibitor of the mdm2:p53 axis for the treatment of dedifferentiated liposarcoma.

Year: 2015

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.725855262.793511567

Authors: R Lor Randall, Matthew Cable

Institutions: Huntsman Cancer Institute, Louisiana State University Health Sciences Center New Orleans

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4230855421

Cites:

Cited by:

Related to: 10